Illumina Production Sequencing at the DOE Joint Genome Institute - Workflow and Optimizations

Tarver, Angela ; Fern, Alison ; Diego, Matthew San ; Kennedy, Megan ; Zane, Matthew ; Daum, Christopher ; Hack, Christopher ; Tang, Eric ; Deshpande, Shweta ; Cheng, Jan-Fang ; Roberts, Simon ; Alexandre, Melanie ; Harmon-Smith, Miranda ; Lucas, Susan

关键词: 59;    DNA;    DNA SEQUENCING;    HUMAN FACTORS ENGINEERING;    MANAGEMENT;    OPTIMIZATION;    PRODUCTION;   

DOI  :  10.2172/985905
RP-ID  :  LBNL-3724E-Poster
PID  :  OSTI ID: 985905
Others  :  TRN: US201017%%242

美国|英语

来源: SciTech Connect

【 摘 要 】

The U.S. Department of Energy (DOE) Joint Genome Institute?s (JGI) Production Sequencing group is committed to the generation of high-quality genomic DNA sequence to support the DOE mission areas of renewable energy generation, global carbon management, and environmental characterization and clean-up. Within the JGI?s Production Sequencing group, the Illumina Genome Analyzer pipeline has been established as one of three sequencing platforms, along with Roche/454 and ABI/Sanger. Optimization of the Illumina pipeline has been ongoing with the aim of continual process improvement of the laboratory workflow. These process improvement projects are being led by the JGI?s Process Optimization, Sequencing Technologies, Instrumentation& Engineering, and the New Technology Production groups. Primary focus has been on improving the procedural ergonomics and the technicians? operating environment, reducing manually intensive technician operations with different tools, reducing associated production costs, and improving the overall process and generated sequence quality. The U.S. DOE JGI was established in 1997 in Walnut Creek, CA, to unite the expertise and resources of five national laboratories? Lawrence Berkeley, Lawrence Livermore, Los Alamos, Oak Ridge, and Pacific Northwest ? along with HudsonAlpha Institute for Biotechnology. JGI is operated by the University of California for the U.S. DOE.